APhA Releases Drug Reference for Pharmacy Technicians

Published Online: Tuesday, December 11, 2012

7th edition of The Pharmacy Technician’s Pocket Drug Reference contains drug information that a pharmacy technician seeks.

WASHINGTON, DC – The American Pharmacists Association (APhA) published The Pharmacy Technician’s Pocket Drug Reference, a new edition of its popular pocket drug reference for pharmacy technicians.  

The Pharmacy Technician’s Pocket Drug Reference, 7th edition, by Joyce A. Generali, contains the five main pieces of drug information that a pharmacy technician seeks. For each of 1,200 of the most commonly prescribed drugs—including 93 drugs new to the market since the sixth edition—the book provides generic name (with pronunciation), trade names, therapeutic class, general FDA approved therapeutic uses, and commercially available dosage forms/strengths.

The reference includes the top 200 oral and topical products by retail sales, most oral and topical products approved by the FDA since 1997, plus more than 250 of the top parenteral products. Other features are a top-200 drugs table providing generic and trade names and general uses, a trade-name index and appendices showing common abbreviations used in prescriptions and common conversions.

The author, Joyce A. Generali, BSPharm, MS, FASHP, is Director, Drug Information Center, University of Kansas Medical Center, Kansas City, and Clinical Professor, University of Kansas School of Pharmacy, Lawrence.

The Pharmacy Technician’s Pocket Drug Reference, 7th edition (ISBN 978-1-58212-168-0; softbound; 270 pages; $24.95 [$20.00 for APhA members]), may be ordered online at www.pharmacist.com/shop or by phone at 800-878-0729.

Latest Articles
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.
Chronic kidney disease incidence has grown faster than many of its common comorbidities such as diabetes and hypertension, and medications may be an underappreciated driver of this growth.
President Barack Obama’s fiscal year 2017 budget proposal calls for an additional $1.1 billion to combat the nation’s spiraling opioid epidemic.
Baxter International is voluntarily recalling intravenous solution due to leaking containers and the potential for particulate matter.
Latest Issues
$auto_registration$